Logo image
Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation
Journal article   Open access   Peer reviewed

Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation

Timothy D Starner, W Edward Swords, Michael A Apicella and Paul B McCray Jr
Infection and immunity, Vol.70(9), pp.5287-5289
09/2002
DOI: 10.1128/IAI.70.9.5287-5289.2002
PMCID: PMC128250
PMID: 12183584
url
https://doi.org/10.1128/IAI.70.9.5287-5289.2002View
Published (Version of record) Open Access

Abstract

Nontypeable Haemophilus influenzae (NTHI) lipooligosaccharide htrB mutants exhibited greater than 45-fold-increased sensitivity to human beta-defensin 2 (HBD-2) compared to the wild type. Complementation by htrB in trans to acylation competence reversed this increased sensitivity. In contrast, NTHI was more susceptible to HBD-3 and showed no changes in sensitivity as a result of lipooligosaccharide mutations in oligosaccharide and lipid A biosynthesis genes.
Mutation Genes, Bacterial Haemophilus influenzae - metabolism Lipid A - genetics Lipid A - metabolism Haemophilus influenzae - drug effects Humans Bacterial Proteins - genetics Drug Resistance, Bacterial Lipopolysaccharides - metabolism Haemophilus influenzae - genetics Acyltransferases - metabolism Acyltransferases - genetics Genetic Complementation Test Haemophilus influenzae - immunology beta-Defensins - pharmacology Bacterial Proteins - metabolism Anti-Bacterial Agents - pharmacology In Vitro Techniques Acylation

Details

Metrics

Logo image